AimwellBio Secures Patented Behavioral AI Portfolio Backed by Oxford Science and Sanofi Pilot; Inventor Dr. Chris A. Jones Joins Board of AdvisorsMorningStar·1 day ago, 07:59 AMSNY+1.26%
Recursion Pharmaceuticals Highlights AI Platform, Roche Progress and Pipeline UpdatesMarket Beat·1 day ago, 12:01 AMRXRX-5.69%SNY+1.26%
MacroGenics Q2 FY26 turns to net income of $19.52 million; revenue more than doubled to $32.83 millionPUBT·Aug 13 at 03:14 PMMGNX+1.48%SNY+1.26%
Sanofi: Information concerning the total number of voting rights and shares - July 2026Unusual Whales·Aug 13 at 11:36 AMSNY+1.26%
Latigo Biotherapeutics files initial beneficial ownership statement for SanofiPUBT·Aug 12 at 07:10 AMLTGO+1.30%SNY+1.26%
Adagene FY26 H1 net loss widens to US$ 16.4 million; revenue turns to US$ 1.6 millionPUBT·Aug 12 at 06:38 AMADAG+6.79%SNY+1.26%
Regeneron posts transcript of Q2 2026 earnings conference callPUBT·Aug 6 at 01:48 PMREGN+1.57%SNY+1.26%
Novavax Q2 FY26 turns to net loss of $53.39 million; revenue drops 76.29% to $56.7 millionPUBT·Aug 6 at 06:54 AMNVAX-2.29%SNY+1.26%
Key facts: Kymera (KYMR) Q2 $65M; $1.5B cash; KT-621 data end-2026TradingView·Aug 6 at 02:15 AMKYMR-1.41%SNY+1.26%
Nurix Therapeutics (NASDAQ:NRIX) Insider Sells 4,356 Shares of StockMarket Beat·Aug 5 at 06:23 PMNRIX-1.21%SNY+1.26%
Kymera Q2 2026 Earnings: Milestone Revenue Narrows Net LossTradingKey·Aug 5 at 06:45 AMKYMR-1.41%GILD+3.12%
Why Investors Should Look at L3Harris, Cenovus, and SanofiBaystreet·Aug 5 at 03:41 AMSNY+1.26%CVE+0.67%
